Shamir Mehta

Editor’s note: This research was published in JAMA Cardiology on Sept. 21, 2022.

PCI improves angina-related quality of life in patients with STEMI and multi-vessel CAD – no matter whether that involves culprit-only lesions or complete revascularization.

PHRI Senior Scientist Shamir Mehta presented this finding of a pre-specified analysis of the COMPLETE trial at ACC 2022 today in Washington, DC, as Featured Clinical Research.

Mehta told TCTMD that “this analysis looked at patient-reported outcomes, so these are patients telling us how they feel and how the quality of their life has improved. I think it’s complementary to the hard outcomes [in COMPLETE] that were reported by physicians, with a very clear benefit in preventing angina.” He added:

“Although the [improved QoL] finding is likely intuitive to many practicing interventional cardiologists, this is the first time we’ve actually shown it.”

C. Michael Gibson interviewed Mehta on the results of the new pre-specified analysis during the ACC 2022 event.

The study that stood out the most at ACC 2022

Deepak Bhatt, a doctor and researcher at Brigham and Women’s Hospital, named COMPLETE’s analysis as a highlight of ACC for him. This Practical Cardiology article includes a short video of Bhatt discussing why he finds is so significant.

Here are some of Mehta’s slides during his Featured Clinical Research presentation at ACC, via Twitter:

Back To Top